Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, et al
Manufacturer savings are available for some people with private insurance (Merck savings card), but dont apply to Medicare or Medicaid
Non-stimulants like atomoxetine may have different effects, often with less initial appetite suppression but still potential for weight changes due to metabolic or behavioral shifts
The US food and drug administration (FDA) has approved a daily pill version of Novo Nordisks weight-loss drug Wegovy, offering patients an oral alternative to injectable medicines that have reshaped obesity treatment.The drug, branded simply as the Wegovy pill, contains semaglutide, the same active ingredient used in injectable Wegovy and diabetes medication Ozempic
Due to the lack of standardisation the manufacturer can print more or less what they want on their batteries